Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle clinical trials

Explore recruiting systemic lupus erythematosus sle and cutaneous lupus erythematosus cle clinical trials.

Recruiting systemic lupus erythematosus sle and cutaneous lupus erythematosus cle studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lupus Erythematosus (Subacute Cutaneous Lupus Erythematosus and/or Discoid Lupus Erythematosus) Participants Receiving Standard of Care

Spain, Greece, Romania, Poland, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Double-blind, Dose-Ranging, Parallel, Long-term Extension Study to Evaluate the Safety and Efficacy of Enpatoran in Participants with Subacute Cutaneous Lupus Erythematosus, Discoid Lupus Erythematosus and/or Systemic Lupus Erythematosus Having Completed the WILLOW (MS200569_0003) Study Treatment (WILLOW LTE)

Greece, Poland, Romania, Spain, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of Renal Impairment on Enpatoran Pharmacokinetics

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle trials by city

Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Toronto Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Vancouver Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Montreal Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Calgary Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Edmonton Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Ottawa Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Winnipeg Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Quebec City Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Hamilton Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Kitchener Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in London Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Halifax Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in New York Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Los Angeles Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Chicago Systemic Lupus Erythematosus Sle And Cutaneous Lupus Erythematosus Cle in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease